Lymphoid tissue located in the head and neck region include multiple regional lymph node chains as well as mucosa associated lymphoid tissue of the conjunctiva, buccal and nasopharyngeal cavities (Waldeyer's ring), and thyroid and salivary glands. This region is a rich source of antigenic stimuli including infectious agents coming from the outside environment. Many reactive conditions that affect lymphoid tissue in this region may mimic neoplasia. In fact, distinguishing between benign and malignant lymphoid proliferations in the head and neck region is a relatively frequent diagnostic challenge and in many instances, this distinction is not straightforward. It therefore behooves the practicing pathologist to be able to recognize the benign lymphoproliferative disorders that affect this region so as to effectively guide the appropriate clinical management of such patients. Kimura disease, Epstein Barr lymphadenitis, HIV associated salivary gland disease and chronic sialadenitis are benign conditions that not infrequently affect 2 lymphoid tissue in the head and neck region and that share certain overlapping features with malignant lymphoma. In this brief review, we discuss these conditions and highlight clinicopathological features that may help distinguish them from neoplastic lymphoproliferations that may share similar features.
Introduction
The head and neck region represents about 10% of the total body surface area and contains several mucosal surfaces, including buccal, nasopharyngeal and ocular, that can serve as ports of entry for antigens into the body's internal environment. Consequently, this region is rich in lymphoid tissue that is strategically located to survey, process and eliminate potentially harmful antigens. Head and neck lymphoid tissue includes mucosa associated lymphoid tissue (MALT) of the buccal and nasopharyngeal cavities (Waldeyer's ring), conjunctiva, and thyroid and salivary glands. There are also multiple regional lymph node chains. These are constantly bombarded by external antigenic stimuli and are frequently enlarged or tender in response to viral, bacterial and other infectious lymphadenitis. Non-neoplastic lymphadenopathy such as those associated with autoimmune diseases and iatrogenic causes (such as certain drugs) also frequently affect head and neck lymphoid tissue. In fact, it is not uncommon for the practicing pathologist to be faced with the challenge of distinguishing between reactive and neoplastic lymphoid proliferations in this region.(1) From a histopathological stand point, it is important to consider both the overall architecture of the lymphoid tissue as well as the cytological features of the proliferating cells in order to help make the distinction between a reactive and neoplastic process. Reactive conditions generally show overall preservation of normal lymphoid architectural features including intact B-cell (lymphoid follicles) and T-cell (inter-follicular and paracortical) areas, even if there is overall expansion (lymphoid hyperplasia) or partial distortion of one or more of the components.
Neoplastic processes, on the other hand, frequently disrupt or replace the normal architecture.
Here we review four selected non-neoplastic entities that affect head and neck lymphoid tissue and can mimic lymphoid neoplasia.
Kimura Disease
Kimura disease is a rare chronic inflammatory disorder with a predilection for the head and neck region. First described in the Chinese literature in 1937 as "eosinophilic hyperplastic lymphogranuloma", the disease acquired its current eponymous designation from Kimura who published a series in the Japanese literature in 1948.(2-4) However, the true incidence of Kimura disease is not known. Most cases have been described in mainland China and Japan where the disease occurs predominantly in young males. (8) included 21 patients of different ethnicities including Caucasian (7), Black (6), Asian (6), Hispanic and Arabic (1 each) with a male: female ratio of 6:1 and a mean age of 31 years (range 8 to 64). These findings are comparable to those described in similar case series reported in the Japanese and Chinese literature. (6, 7) The etiology of Kimura disease is unknown. It is considered to represent a chronic inflammatory disorder, possibly due to a hitherto unidentified antigenic stimulus.
Infectious agents such as viruses, parasites and Candida albicans and toxins have been proposed as possible triggers, but there is no conclusive evidence to support any specific inciting factor.(9) Patients usually present with single or multiple painless subcutaneous masses in the head and neck region, including the face, neck and periauricular areas. (6) Enlarged regional lymph nodes are frequently present and the reported frequency of clinically detectable regional lymphadenopathy ranges from 32 to 100%. (6, 10) Subcutaneous tissue and lymph node groups outside of the head and neck region may also be involved, at times without apparent head and neck disease.(6, 7, 10) Unilateral or bilateral involvement of parotid and submandibular salivary glands may lead to swelling and lacrimal gland involvement has been reported in at least one patient. (6) In addition, peripheral blood eosinophilia, frequently above 10%, and elevated serum IgE and eosinophil cationic protein levels are invariably present. (7, 11, 12) Renal disease, usually in the form of nephrotic-level proteinuria, is seen in up to 16% of patients. The natural history of Kimura disease is not well described. In most patients, the disease shows a prolonged, indolent clinical course. In the AFIP series, the majority had complete remission with no evidence of disease even with long term follow up while one 6 patient still had evidence of disease more than 12 years after initial presentation. Longterm oral corticosteroids seem to be the mainstay of treatment of Kimura disease whereas surgical resection and radiation have limited roles in localized disease. Multifocal disease outside of the parotid glands, eosinophils > 50% and IgE levels >10,000 IU/ml have been shown to be associated with recurrent disease. (22, 46) . Therefore, demonstration of clonality in the absence of an expansion of these B-cell clones, it is controversial whether they represent the very early manifestation of lymphoma, and a diagnosis of ENMZBCL is discouraged.
In early ENMZBCL, there is an expansion of monocytoid cells to form broad halos and bands around the lymphoepithelial islands (22, 46) , and clonality is demonstrated either by PCR gene rearrangement study or flow cytometry light chain restriction. If clonality is absent, a diagnosis of early ENMZBCL is also discouraged, and patients will be 
